Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis

doi:10.3748/wjg.14.53

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4168)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

364

HTML

3506

Figures (1-3)

162

Tables (1-2)

136

Sum=4168

Jan 7, 2008 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (75)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Jan 7, 2008; 14(1): 53-57
Published online Jan 7, 2008. doi: 10.3748/wjg.14.53

Full Size Figure Download Figure

Figure 1 Concentrations of fecal calprotectin, CRP, ESR and AGP in the UC patients and the controls. UC (A): Ulcerative colitis (active phase); UC (I): Ulcerative colitis (inactive phase). ^aP < 0.05 vs the control, ^bP < 0.01 vs UC (I) and the control, ^cP > 0.05 vs the control, ^eP < 0.05 vs UC (I) and the control.

Citation: Xiang JY, Ouyang Q, Li GD, Xiao NP. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World J Gastroenterol 2008; 14(1): 53-57
URL: https://www.wjgnet.com/1007-9327/full/v14/i1/53.htm
DOI: https://dx.doi.org/10.3748/wjg.14.53